Andrew Whitman joined Vantive (formerly Baxter Kidney Care) in 2023 to serve as the Executive Vice President and Head of Corporate Affairs. Andrew oversees Government Affairs, Reimbursement & Market Access, Corporate Social Responsibility and Sustainability functions for the company. Prior to that Andrew served as Senior Vice President, Government Affairs & Market Development overseeing the Americas and Asia markets for Siemens Healthineers. He served in a similar global role for Varian since 2008, before the acquisition of Varian by Siemens Healthineers in 2021. In this role, his responsibility includes advocating for Siemens Healthineers as the preferred partner to governments for increasing patients’ and health systems’ access to Siemens Healthineers’ healthcare innovations across the globe.

Prior to joining Siemens Healthineers, Mr. Whitman was Vice President for the Medical Imaging & Technology Alliance, a National Electrical Manufacturers Association division. In addition, he previously worked at the Carmen Group, Inc., a government relations firm in Washington, D.C., where he served as the Senior Associate for Healthcare Practice, representing healthcare providers on Capitol Hill and the U.S. Department of Health and Human Services.

Before his role at the Carmen Group, Inc., Mr. Whitman served as Deputy Director, Regulatory Affairs and Special Counsel for the American Psychiatric Association, directing and managing the federal regulatory and healthcare policy agenda. He also served as Senior Counsel for the U.S. Department of Health and Human Services in the Office of Counsel to the Inspector General and Senior Corporate Counsel for Integrated Health Services, Inc.

Mr. Whitman has practiced healthcare law at several law firms, including Reed Smith, LLP and Grove, and Jaskiewicz and Cobert. He holds a Juris Doctorate from American University and a bachelor’s degree, cum laude, from Hamilton College.